Solvay opts for strategic refocus of activities
Decision to sell Pharmaceuticals Sector to Abbott
See also the attached PDF files:
For further information please contact:
Patrick Verelst, Head of Investor Relations
SOLVAY SA
Tel: 32 2 509 72 43
Fax: 32 2 509 72 40
E-mail: patrick.verelst@solvay.com
Erik De Leye, Corporate Press Officer
SOLVAY SA
Tel: 32 2 509 72 30
Fax: 32 2 509 72 40
E-mail: erik.deleye@solvay.com